Global Intragastric Balloons Market Size, Share & Trends Analysis Report By Balloon Type (Single, Dual), By Filling Material (Saline Filled, Gas Filled), By End Use, By Administration, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

The global intragastric balloons market size was exhibited at USD 15.90 million in 2023 and is projected to hit around USD 50.27 million by 2033, growing at a CAGR of 12.2% during the forecast period of 2024 to 2033.

Intragastric Balloons Market Size 2024 To 2033

Key Takeaways:

  • North America dominated the market and accounted for the largest revenue share of 40.0% in 2023 in the intragastric balloons market.
  • The endoscopy segment dominated the market for the intragastric balloon and held the largest revenue share of 69.8% in 2023. 
  • The saline-filled segment dominated the market for the intragastric balloon and held the largest revenue share of 71.1% in 2023 
  • The single segment dominated the market for the intragastric balloon and held the largest revenue share of 75.2% in 2023
  • The hospital segment dominated the market for the intragastric balloon and held the largest revenue share of 47.0% in 2023.

Intragastric Balloons Market Report Scope

 Report Coverage  Details
Market Size in 2024 USD 15.90 Million
Market Size by 2033 USD 50.27 Million
Growth Rate From 2024 to 2033 CAGR of 12.2%
Base Year 2023
Forecast Period 2024-2033
Segments Covered Administration, Balloon Type, Filling Material, End-use, Region
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Regional Scope North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa
Key Companies Profiled Apollo Endosurgery, Inc.; Obalon Therapeutics, Inc.; Allurion Technologies, Inc.; Spatz3; Helioscopie; Endalis; MEDSIL; ReShape Medical, Inc.; Lexel Medical.

 

The increasing prevalence of obesity is anticipated to drive market growth. Furthermore, the rise in demand for minimally invasive procedures is anticipated to further boost the market growth.

Obesity is a major health concern across the globe. The obesity pandemic is expected to continue increasing over the forecast period, thus fueling the market growth. For instance, according to the World Health Organization (2016) data, nearly 2 billion individuals were overweight, and out of which around 650 million were obese. In addition, it is estimated that, by 2025, 2.7 billion individuals will be overweight and around 1.0 billion will be obese.

Despite the high prevalence of obesity and the wide acceptance of weight-loss surgical procedures (such as gastric bypass and sleeve gastrectomy) by healthcare professionals, merely 1% or 2% of the obese population is eligible for these surgeries leading to high mortality due to obesity. For instance, according to World Health Organization data, globally, nearly 2.8 million individuals die each year due to obesity or overweight. This high mortality is anticipated to fuel demand for alternate and minimally invasive procedures such as an intragastric balloon.

The American Society for Metabolic and Bariatric Surgery (ASMBS) included the intragastric balloon in the list of procedures and devices approved by the society as a treatment option, in 2023. The sanction and endorsements of this treatment by the ASMBS is anticipated to increase the adoption of intragastric balloons.

The high costs and procedural complications associated with aspiration therapy and neuroblocking therapy is anticipated to increase the demand for intragastric balloons. Furthermore, the development of novel intragastric balloons to overcome the shortcomings of conventional balloons is anticipated to further boost market demand. For instance, the magnetic soft endoscopic capsule-inflated intragastric balloon developed in collaboration with Nanyang Technological University, Singapore, is a biocompatible, acid-resistant and robot system for weight loss, thus reducing the need for complex insertion tools and the likelihood of adverse effects.

Segments Insights:

Administration Insights

The endoscopy segment dominated the market for the intragastric balloon and held the largest revenue share of 69.8% in 2023. Emerging endoscopic technologies are able to reproduce the few of the anatomic modifications performed during weight loss surgery and are equally effective. In addition, endoscopic technologies are less invasive and cost-effective when compared to bariatric surgery. These factors are anticipated to contribute towards segment growth.

The pill form segment is anticipated to witness lucrative growth over the forecast period. This can be attributed to the non-surgical nature of the technique, reversible treatment, and availability of swallowable capsule which enables easy ingestion and excretion of the intragastric balloon.

Filling Material Insights

The saline-filled segment dominated the market for the intragastric balloon and held the largest revenue share of 71.1% in 2023 due to the high product availability and significant weight loss produced by these systems. The gas-filled intragastric balloons segment is anticipated to grow at a rapid pace over the forecast period. The adverse events reported due to the use of saline-filled intragastric balloons are driving the demand for alternatives such as gas-filled intragastric balloons.

Balloon Type Insights

The single segment dominated the market for the intragastric balloon and held the largest revenue share of 75.2% in 2023 and the triple segment is anticipated to witness lucrative growth over the forecast period. The single intragastric balloon segment held the largest revenue share owing to the availability of a large number of products in the market and scientific evidence supporting its safety and efficacy. The benefits offered by the existing triple balloon system, such as minimal downtime and fully reversible treatment, are anticipated to increase the demand for this type of intragastric balloon.

End-use Insights

The hospital segment dominated the market for the intragastric balloon and held the largest revenue share of 47.0% in 2023. This can be attributed to the availability of skilled professionals and the presence of sophisticated equipment in hospital settings. In addition, the availability of a large number of weight-loss treatment options requiring hospital stay is anticipated to contribute towards segment share.

Intragastric Balloons Market Share, By End-use, 2023 (%)

Ambulatory surgical centers are anticipated to witness rapid growth over the forecast period due to high costs of hospitalization, rise in demand for minimally invasive procedures and treatment options.

Regional Insights

North America dominated the market and accounted for the largest revenue share of 40.0% in 2023 in the intragastric balloons market. The high prevalence of obesity, availability of skilled professionals, and high adoption of weight loss treatments are some of the major factors contributing to the growth of the market in this region.

Intragastric Balloons Market Share, By Region 2023 (%)

In Asia Pacific, the market for the intragastric balloon is expected to expand at a rapid pace over the forecast period. An increase in the number of obese populations, rise in an unhealthy lifestyle, and availability of treatment at relatively low cost in this region are some of the major factors driving the market in the region.

Some of the prominent players in the intragastric balloons market include:

  • Apollo Endosurgery, Inc.
  • Obalon Therapeutics, Inc.
  • Allurion Technologies, Inc.
  • Spatz3
  • Helioscopie
  • Endalis
  • MEDSIL
  • ReShape Medical, Inc.
  • Lexel Medical

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global intragastric balloons market.

Administration

  • Pill Form
  • Endoscopy

Balloon Type

  • Single
  • Dual
  • Triple

Filling Material

  • Saline Filled
  • Gas Filled

End-use

  • Hospitals
  • Clinics
  • Ambulatory surgical centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global intragastric balloons market size was exhibited at USD 15.90 million in 2023 and is projected to hit around USD 50.27 million by 2033

The global intragastric balloons market is expected to grow at a compound annual growth rate of 12.2% from 2024 to 2033 to reach USD 50.27 million by 2033.

Some key players operating in the intragastric balloons market include Apollo Endosurgery, Inc.; Obalon Therapeutics, Inc.; Allurion Technologies, Inc.; Spatz3; Helioscopie; Endalis; MEDSIL; ReShape Medical, Inc.; and Lexel Medical.

Chapter 1. Methodology and Scope

1.1. Market segmentation & scope

1.2. Information procurement

1.2.1. Purchased database

1.2.2. internal database

1.2.3. Secondary sources & third-party perspectives

1.2.4. Primary research

1.3. Information analysis

1.3.1. Data analysis models

1.4. Market formulation & data visualization

1.5. Data validation & publishing

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. Intragastric Balloon Market Variables, Trends & Scope

3.1. Market Lineage outlook

3.1.1. Related market outlook

3.2. Penetration & Growth Prospect Mapping

3.3. Market Dynamics

3.3.1. Market Driver Analysis

3.3.1.1. Increasing prevalence of obesity

3.3.1.2. Rise in adoption of minimally invasive treatment

3.3.2. Market Restraint Analysis

3.3.2.1. Lack of reimbursement

3.3.2.2. Side effects

3.4. Intragastric Balloon: Market Analysis Tools

3.4.1. Industry Analysis - Porter’s

3.4.1.1. Supplier Power

3.4.1.2. Buyer Power

3.4.1.3. Substitution Threat

3.4.1.4. Threat from new entrant

3.4.1.5. Competitive rivalry

3.4.2. PESTEL Analysis

3.4.2.1. Political Landscape

3.4.2.2. Environmental Landscape

3.4.2.3. Social Landscape

3.4.2.4. Technology Landscape

3.4.2.5. Legal Landscape

3.4.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Intragastric Balloon Market: Segment Analysis, By Administration, 2024 - 2033

4.1. Definitions & Scope

4.2. Administration market share analysis, 2024 & 2033

4.3. Global Intragastric Balloon Market, By Administration, 2021 to 2033

4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

4.4.1. Pill form

4.4.2. Endoscopy

Chapter 5. Intragastric Balloon Market: Segment Analysis, By Balloon Type, 2024 - 2033

5.1. Definitions & Scope

5.2. Balloon Type market share analysis, 2024 & 2033

5.3. Global Intragastric Balloon Market, By Balloon Type, 2021 to 2033

5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

5.4.1. Single

5.4.2. Dual

5.4.3. Triple

Chapter 6. Intragastric Balloon Market: Segment Analysis, By Filling Material, 2024 - 2033

6.1. Definitions & Scope

6.2. Filling Material market share analysis, 2024 & 2033

6.3. Global Intragastric Balloon Market, By Filling Material, 2021 to 2033

6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

6.4.1. Saline Filled

6.4.2. Gas Filled

Chapter 7. Intragastric Balloon Market: Segment Analysis, By End Use, 2024 - 2033

7.1. Definitions & Scope

7.2. End-use market share analysis, 2024 & 2033

7.3. Global Intragastric Balloon Market, By End Use, 2021 to 2033

7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

7.4.1. Hospitals

7.4.2. Ambulatory Surgical Centers

7.4.3. Clinics

Chapter 8. Intragastric Balloon Market: Regional Market Analysis, By Region, 2024 - 2033

8.1. Definitions & Scope

8.2. Regional market share analysis, 2024 & 2033

8.3. Regional Market Dashboard

8.4. Regional Market: Key Players

8.5. Market Size, & Forecasts, and Trend Analysis, 2024 to 2033:

8.6. North America

8.6.1. Market estimates and forecast, by country, 2021 - 2033

8.6.2. Market estimates and forecast, by administration, 2021 - 2033

8.6.3. Market estimates and forecast, by filling material, 2021 - 2033

8.6.4. Market estimates and forecast, by balloon type, 2021 - 2033

8.6.5. Market estimates and forecast, by end use, 2021 - 2033

8.6.6. U.S.

8.6.6.1. Market estimates and forecast, by administration, 2021 - 2033

8.6.6.2. Market estimates and forecast, by filling material, 2021 - 2033

8.6.6.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.6.6.4. Market estimates and forecast, by end use, 2021 - 2033

8.6.7. Canada

8.6.7.1. Market estimates and forecast, by administration, 2021 - 2033

8.6.7.2. Market estimates and forecast, by filling material, 2021 - 2033

8.6.7.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.6.7.4. Market estimates and forecast, by end use, 2021 - 2033

8.7. Europe

8.7.1. Market estimates and forecast, by country, 2021 - 2033

8.7.2. Market estimates and forecast, by administration, 2021 - 2033

8.7.3. Market estimates and forecast, by filling material, 2021 - 2033

8.7.4. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.5. Market estimates and forecast, by end use, 2021 - 2033

8.7.6. Germany

8.7.6.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.6.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.6.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.6.4. Market estimates and forecast, by end use, 2021 - 2033

8.7.7. U.K.

8.7.7.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.7.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.7.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.7.4. Market estimates and forecast, by end use, 2021 - 2033

8.7.8. France

8.7.8.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.8.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.8.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.8.4. Market estimates and forecast, by end use, 2021 - 2033

8.7.9. Italy

8.7.9.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.9.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.9.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.9.4. Market estimates and forecast, by end use, 2021 - 2033

8.7.10. Spain

8.7.10.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.10.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.10.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.10.4. Market estimates and forecast, by end use, 2021 - 2033

8.7.11. Switzerland

8.7.11.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.11.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.11.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.11.4. Market estimates and forecast, by end use, 2021 - 2033

8.7.12. Belgium

8.7.12.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.12.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.12.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.12.4. Market estimates and forecast, by end use, 2021 - 2033

8.7.13. Poland

8.7.13.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.13.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.13.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.13.4. Market estimates and forecast, by end use, 2021 - 2033

8.7.14. The Netherlands

8.7.14.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.14.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.14.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.14.4. Market estimates and forecast, by end use, 2021 - 2033

8.7.15. Turkey

8.7.15.1. Market estimates and forecast, by administration, 2021 - 2033

8.7.15.2. Market estimates and forecast, by filling material, 2021 - 2033

8.7.15.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.7.15.4. Market estimates and forecast, by end use, 2021 - 2033

8.8. Asia Pacific

8.8.1. Market estimates and forecast, by country, 2021 - 2033

8.8.2. Market estimates and forecast, by administration, 2021 - 2033

8.8.3. Market estimates and forecast, by filling material, 2021 - 2033

8.8.4. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.5. Market estimates and forecast, by end use, 2021 - 2033

8.8.6. China

8.8.6.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.6.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.6.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.6.4. Market estimates and forecast, by end use, 2021 - 2033

8.8.7. Japan

8.8.7.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.7.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.7.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.7.4. Market estimates and forecast, by end use, 2021 - 2033

8.8.8. India

8.8.8.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.8.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.8.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.8.4. Market estimates and forecast, by end use, 2021 - 2033

8.8.9. Thailand

8.8.9.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.9.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.9.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.9.4. Market estimates and forecast, by end use, 2021 - 2033

8.8.10. South Korea

8.8.10.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.10.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.10.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.10.4. Market estimates and forecast, by end use, 2021 - 2033

8.8.11. Australia

8.8.11.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.11.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.11.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.11.4. Market estimates and forecast, by end use, 2021 - 2033

8.8.12. Malaysia

8.8.12.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.12.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.12.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.12.4. Market estimates and forecast, by end use, 2021 - 2033

8.8.13. Singapore

8.8.13.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.13.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.13.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.13.4. Market estimates and forecast, by end use, 2021 - 2033

8.8.14. Indonesia

8.8.14.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.14.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.14.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.14.4. Market estimates and forecast, by end use, 2021 - 2033

8.8.15. Philippines

8.8.15.1. Market estimates and forecast, by administration, 2021 - 2033

8.8.15.2. Market estimates and forecast, by filling material, 2021 - 2033

8.8.15.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.8.15.4. Market estimates and forecast, by end use, 2021 - 2033

8.9. Latin America

8.9.1. Market estimates and forecast, by country, 2021 - 2033

8.9.2. Market estimates and forecast, by administration, 2021 - 2033

8.9.3. Market estimates and forecast, by filling material, 2021 - 2033

8.9.4. Market estimates and forecast, by balloon type, 2021 - 2033

8.9.5. Market estimates and forecast, by end use, 2021 - 2033

8.9.6. Brazil

8.9.6.1. Market estimates and forecast, by administration, 2021 - 2033

8.9.6.2. Market estimates and forecast, by filling material, 2021 - 2033

8.9.6.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.9.6.4. Market estimates and forecast, by end use, 2021 - 2033

8.9.7. Mexico

8.9.7.1. Market estimates and forecast, by administration, 2021 - 2033

8.9.7.2. Market estimates and forecast, by filling material, 2021 - 2033

8.9.7.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.9.7.4. Market estimates and forecast, by end use, 2021 - 2033

8.9.8. Argentina

8.9.8.1. Market estimates and forecast, by administration, 2021 - 2033

8.9.8.2. Market estimates and forecast, by filling material, 2021 - 2033

8.9.8.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.9.8.4. Market estimates and forecast, by end use, 2021 - 2033

8.9.9. Chile

8.9.9.1. Market estimates and forecast, by administration, 2021 - 2033

8.9.9.2. Market estimates and forecast, by filling material, 2021 - 2033

8.9.9.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.9.9.4. Market estimates and forecast, by end use, 2021 - 2033

8.9.10. Colombia

8.9.10.1. Market estimates and forecast, by administration, 2021 - 2033

8.9.10.2. Market estimates and forecast, by filling material, 2021 - 2033

8.9.10.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.9.10.4. Market estimates and forecast, by end use, 2021 - 2033

8.10. Middle East and Africa

8.10.1. Market estimates and forecast, by country, 2021 - 2033

8.10.2. Market estimates and forecast, by administration, 2021 - 2033

8.10.3. Market estimates and forecast, by filling material, 2021 - 2033

8.10.4. Market estimates and forecast, by balloon type, 2021 - 2033

8.10.5. Market estimates and forecast, by end use, 2021 - 2033

8.10.6. South Africa

8.10.6.1. Market estimates and forecast, by administration, 2021 - 2033

8.10.6.2. Market estimates and forecast, by filling material, 2021 - 2033

8.10.6.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.10.6.4. Market estimates and forecast, by end use, 2021 - 2033

8.10.7. Saudi Arabia

8.10.7.1. Market estimates and forecast, by administration, 2021 - 2033

8.10.7.2. Market estimates and forecast, by filling material, 2021 - 2033

8.10.7.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.10.7.4. Market estimates and forecast, by end use, 2021 - 2033

8.10.8. UAE

8.10.8.1. Market estimates and forecast, by administration, 2021 - 2033

8.10.8.2. Market estimates and forecast, by filling material, 2021 - 2033

8.10.8.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.10.8.4. Market estimates and forecast, by end use, 2021 - 2033

8.10.9. Israel

8.10.9.1. Market estimates and forecast, by administration, 2021 - 2033

8.10.9.2. Market estimates and forecast, by filling material, 2021 - 2033

8.10.9.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.10.9.4. Market estimates and forecast, by end use, 2021 - 2033

8.10.10. Egypt

8.10.10.1. Market estimates and forecast, by administration, 2021 - 2033

8.10.10.2. Market estimates and forecast, by filling material, 2021 - 2033

8.10.10.3. Market estimates and forecast, by balloon type, 2021 - 2033

8.10.10.4. Market estimates and forecast, by end use, 2021 - 2033

Chapter 9. Intragastric Balloon Market - Competitive Analysis

9.1. Key companies profiled

9.1.1. Apollo Endosurgery, Inc.

9.1.1.1. Company Overview

9.1.1.2. Financial Performance

9.1.1.3. Product Benchmarking

9.1.1.4. Strategic Initiatives

9.1.2. Obalon Therapeutics, Inc

9.1.2.1. Company Overview

9.1.2.2. Financial Performance

9.1.2.3. Product Benchmarking

9.1.2.4. Strategic Initiatives

9.1.3. ReShape Medical, Inc

9.1.3.1. Company Overview

9.1.3.2. Financial Performance

9.1.3.3. Product Benchmarking

9.1.3.4. Strategic Initiatives

9.1.4. Allurion Technologies, Inc.

9.1.4.1. Company Overview

9.1.4.2. Financial Performance

9.1.4.3. Product Benchmarking

9.1.4.4. Strategic Initiatives

9.1.5. Spatz3

9.1.5.1. Company Overview

9.1.5.2. Financial Performance

9.1.5.3. Product Benchmarking

9.1.5.4. Strategic Initiatives

9.1.6. Helioscopie

9.1.6.1. Company Overview

9.1.6.2. Product Benchmarking

9.1.6.3. Strategic Initiatives

9.1.7. Endalis

9.1.7.1. Company Overview

9.1.7.2. Financial Performance

9.1.7.3. Product Benchmarking

9.1.8. MEDSIL

9.1.8.1. Company Overview

9.1.8.2. Financial Performance

9.1.8.3. Product Benchmarking

9.1.8.4. Strategic Initiatives

9.1.9. Lexel Medical

9.1.9.1. Company Overview

9.1.9.2. Financial Performance

9.1.9.3. Product Benchmarking

 

9.1.9.4. Strategic Initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers